₹ 56.7 Cr
Volume transacted
330.6 K
stocks traded
Last Updated time: 26 Jul 9.00 AM
Sun Pharmaceuticals Industries Ltd
NSE: SUNPHARMA
DPS
₹ 13.5
Last updated : FY 2024
The Dividend per Share of Sun Pharmaceuticals Industries Ltd is ₹ 13.5 as of 2024 .a1#The Dividend Payout of Sun Pharmaceuticals Industries Ltd changed from 80.8 % on March 2019 to 113.33 % on March 2024 . This represents a CAGR of 5.80% over 6 years. a1#The Latest Trading Price of Sun Pharmaceuticals Industries Ltd is ₹ 1713 as of 26 Jul 15:30 .a1#The Market Cap of Sun Pharmaceuticals Industries Ltd changed from ₹ 114988 crore on March 2019 to ₹ 388812 crore on March 2024 . This represents a CAGR of 22.51% over 6 years. a1#The Revenue of Sun Pharmaceuticals Industries Ltd changed from ₹ 10763 crore to ₹ 12588 crore over 8 quarters. This represents a CAGR of 8.15% a1#The EBITDA of Sun Pharmaceuticals Industries Ltd changed from ₹ 2886 crore to ₹ 3539 crore over 8 quarters. This represents a CAGR of 10.73% a1#The Net Pr of Sun Pharmaceuticals Industries Ltd changed from ₹ 2095 crore to ₹ 2666 crore over 8 quarters. This represents a CAGR of 12.80% a1#
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
Market Cap
₹ 399,537 Cr
EPS
₹ 41.6
P/E Ratio (TTM) *
40.0
P/B Ratio (TTM) *
6.3
DTE *
0.1
ROE *
15.0
ROCE *
16.8
Dividend Yield *
0.83
DPS *
13.5
Dividend Payout *
113.33
Ann.Dividend % *
1350
* All values are consolidated
Last Updated time: 26 Jul 9.00 AM
* All values are consolidated
Last Updated time: 26 Jul 9.00 AM
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Period | |
---|---|
Mar '19 | 81 |
Mar '20 | 30 |
Mar '21 | 214 |
Mar '22 | -2400 |
Mar '23 | 163 |
Mar '24 | 113 |
* All values are a in %
Dividend Yield is a financial ratio that shows the annual dividend income relative to the market price of a share. It is calculated by dividing the dividend per share by the current market price per share, expressed as a percentage.
* All values are in %
Sun Pharmaceuticals Industries Ltd
NSE: SUNPHARMA
PRICE
₹ 1713.6
48.40 (2.91%)
Last updated : 26 Jul 15:30
Strength
2
S
Weakness
2
W
Opportunity
0
O
Threats
1
T
Revenue
Profitability
Affordability
Liquidity
Dividend
A dividend is paid on common stock when a company has accumulated substantial profits over years, often seen as excess cash that doesn't need immediate use.
A quarterly dividend is paid to preferred stock owners, typically accumulating a fixed amount, and is earned on shares that function more like bonds.
Companies declare interim dividends before final full-year accounts are prepared, specifically in India, during the financial year from April to March of the following year.
A final dividend is issued after the year's accounts have been compiled. Aside from this, the following list highlights the most prevalent sorts of dividends:
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Period | |
---|---|
Mar '19 | 114988 |
Mar '20 | 84505 |
Mar '21 | 143384 |
Mar '22 | 219491 |
Mar '23 | 235879 |
Mar '24 | 388812 |
* All values are a in ₹crore
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Period | |
---|---|
Jun '22 | 10764 |
Sep '22 | 11038 |
Dec '22 | 11415 |
Mar '23 | 11304 |
Jun '23 | 12145 |
Sep '23 | 12486 |
Dec '23 | 12631 |
Mar '24 | 12589 |
* All values are a in ₹crore
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Period | |
---|---|
Jun '22 | 2887 |
Sep '22 | 3042 |
Dec '22 | 3178 |
Mar '23 | 3004 |
Jun '23 | 3213 |
Sep '23 | 3473 |
Dec '23 | 3657 |
Mar '24 | 3539 |
* All values are a in ₹crore
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Period | |
---|---|
Jun '22 | 2096 |
Sep '22 | 2260 |
Dec '22 | 2188 |
Mar '23 | 2017 |
Jun '23 | 2013 |
Sep '23 | 2401 |
Dec '23 | 2568 |
Mar '24 | 2667 |
* All values are a in ₹crore
Sun Pharmaceutical Industries Limited including its subsidiaries and associates (Sun Pharma) is the fourth largest global specialty generic company that is ranked No. In the year 1998, the company established their first research center, SPARC and this created the base for strong product and process development that enabled growth in the subsequent years. Also, the company acquired equity stake in Gujarat Lyka Organics Ltd., a manufacturer of Cephalexin Active with a USFDA approval for the intermediate, 7ADCA. In the year 1998, the company acquired a basket of products, including several respiratory/asthma brands acquired from Natco Pharma. During the year, the company completed the construction at a formulation manufacturing site at Jammu. In June 14, 2011, Caraco Pharmaceutical Laboratories Ltd (Caroco) merged with a subsidiary of the company. The Company announces USFDA approval for generic Prevacid, generic DoxilAr and generic DepoAr-Testosterone Injection. The acquired brands will be marketed by a reliable and established local marketing partner under the Sun Pharma label. The purpose of the buyback is to return surplus funds to the equity shareholders and thereby, enhancing the overall returns to shareholders. On 18 July 2016, Sun Pharma and Sun Pharma Advanced Research Company Ltd. (SPARC) announced a licensing arrangement for SPARC's ELEPSIA XR (Levetiracetam Extended Release tablets). Sun Pharma will be eligible to receive development and regulatory milestone payments and, additionally, sales milestone payments and royalties on net sales. It was the first branded product launched by the company in the USA following its focus on Specialty Business. On 22 December 2016, Sun Pharma announced its plans to acquire a branded oncology product Odomzo from Novartis. The agreement was signed for an upfront payment of US$ 175 million and additional milestone payments. The USFDA had taken action against the Mohali facility in 2013 when it ordered the facility to be fully subject to Ranbaxy's Consent Decree of Permanent Injunction. Sun Pharma will provide drug molecules to NIV for testing against Zika, Chikungunya and Dengue in model systems. These RTA bags will provide greater safety, by preventing problems of over-dosing or under-dosing and eliminating contamination risk. In August 2019, Sun Pharma granted an exclusive license to a subsidiary of China Medical System Holdings Ltd. (CMS) to develop and commercialise seven generic products in Mainland China. In November 2019, Sun Pharma entered into a licensing agreement with AstraZeneca UK Ltd. (AstraZeneca) to introduce certain novel ready to use (RTU) infusion oncology products in China. It initiated Phase-2 clinical trials for a potential oral treatment for atopic dermatitis and moderate to severe plaque psoriasis.
Sun Pharma gets US FDA nod for alopecia areata treatment drug LEQSELVI
Alopecia areata is a common autoimmune disease in which hair loss is thought to occur due ...
Read more
26 Jul 202409:42
Sun Pharmaceuticals Industries Ltd spurts 1.88%, rises for fifth straight session
Sun Pharmaceuticals Industries Ltd gained for a fifth straight session today. The stock is...
Read more
26 Jul 202413:00
Sun Pharma receives USFDA approval for LEQSELVI™ (deuruxolitinib) 8 mg tablets
Sun Pharmaceuticals Industries announced that the U.S. Food and Drug Administration (FDA) ...
Read more
26 Jul 202414:26
Sun Pharmaceuticals Industries Ltd rises for third straight session
Sun Pharmaceuticals Industries Ltd is up for a third straight session today. The stock is ...
Read more
24 Jul 202413:05
Sun Pharmaceuticals Industries to discuss results
Sun Pharmaceuticals Industries will hold a meeting of the Board of Directors of the Compan...
Read more
16 Jul 202410:47
Sun Pharma to announces Q1 results on 01 Aug
Sun Pharmaceutical Industries will announce results for the first quarter ended 30 June 20...
Read more
16 Jul 202418:31
FAQs for dividends of Sun Pharmaceuticals Industries Ltd
What is the current market price of Sun Pharmaceuticals Industries Ltd Ltd as of July 26, 2024?
What dividend did Sun Pharmaceuticals Industries Ltd declare in the last fiscal year?
What is the most recent dividend declared by Sun Pharmaceuticals Industries Ltd?
How many times has Sun Pharmaceuticals Industries Ltd declared dividends in the current fiscal year
How many times did Sun Pharmaceuticals Industries Ltd declare dividends in the previous fiscal year?
Unlimited trading at just
Rs. 199